三生國健(688336.SH)股票自2025年5月19日以來,累計升幅超過100%,可能存在非理性炒作和回調
格隆匯5月22日丨三生國健(688336.SH)公佈,截至2025年5月22日,公司收盤價為56.69元/股,根據中證指數有限公司發佈的公司所處的生物藥品行業最近一個月平均滾動市盈率為29.18倍,公司最新滾動市盈率為48.81倍,公司市盈率顯著高於行業市盈率水平。公司股票自2025年5月19日以來,累計升幅超過100%,可能存在非理性炒作和回調。
經公司自查並向控股股東及實際控制人核實,截止本公吿披露日,除公司已披露信息外,公司及公司控股股東、實際控制人不存在籌劃關於公司的應披露而未披露的重大事項的情況,公司日常經營情況正常,未發生重大變化,所處的行業政策未發生重大調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.